MedTrace Logo

Ex Vivo Study of the Heracure Device for Intra-uterine Morcellation After Vaginal or Laparoscopic Hysterectomy

NCT05332132 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-05-25

No results posted yet for this study

Summary

Safety and performance evaluation of the Heracure Device for intra-uterine morcellation after vaginal or laparoscopic hysterectomy.

Conditions

  • Vaginal or Laparoscopic Hysterectomy

Interventions

DEVICE

Heracure Device

Intrauterine Morcellation of Uteri Post-Surgery (Ex Vivo Study)

Sponsors & Collaborators

  • Heracure Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Gal Meister · Sponsor GmbH

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-18
Primary Completion
2022-07-31
Completion
2022-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05332132 on ClinicalTrials.gov